Tower Research Capital (TRC)’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$341K Buy
16,044
+6,769
+73% +$144K 0.01% 1310
2025
Q1
$179K Sell
9,275
-7,661
-45% -$148K 0.01% 1429
2024
Q4
$302K Buy
16,936
+15,440
+1,032% +$276K 0.01% 1403
2024
Q3
$32.8K Sell
1,496
-67,324
-98% -$1.47M ﹤0.01% 2957
2024
Q2
$537K Buy
68,820
+57,666
+517% +$450K 0.01% 1283
2024
Q1
$46.2K Sell
11,154
-9,990
-47% -$41.4K ﹤0.01% 2334
2023
Q4
$55.2K Buy
21,144
+14,384
+213% +$37.5K ﹤0.01% 3063
2023
Q3
$12.6K Buy
6,760
+1,858
+38% +$3.47K ﹤0.01% 3880
2023
Q2
$12.3K Sell
4,902
-15,972
-77% -$40.1K ﹤0.01% 3862
2023
Q1
$36K Sell
20,874
-6,206
-23% -$10.7K ﹤0.01% 2816
2022
Q4
$115K Buy
27,080
+15,689
+138% +$66.6K ﹤0.01% 1729
2022
Q3
$14K Buy
11,391
+2,028
+22% +$2.49K ﹤0.01% 4226
2022
Q2
$9K Buy
9,363
+5,187
+124% +$4.99K ﹤0.01% 4586
2022
Q1
$10K Buy
4,176
+95
+2% +$227 ﹤0.01% 4344
2021
Q4
$11K Buy
4,081
+1,722
+73% +$4.64K ﹤0.01% 4451
2021
Q3
$12K Sell
2,359
-1,077
-31% -$5.48K ﹤0.01% 4170
2021
Q2
$26K Sell
3,436
-1,381
-29% -$10.5K ﹤0.01% 3653
2021
Q1
$28K Buy
4,817
+1,034
+27% +$6.01K ﹤0.01% 3619
2020
Q4
$18K Buy
+3,783
New +$18K ﹤0.01% 3939
2018
Q2
Sell
-472
Closed -$6K 4026
2018
Q1
$6K Buy
+472
New +$6K ﹤0.01% 2668
2017
Q3
Sell
-300
Closed -$3K 4190
2017
Q2
$3K Buy
+300
New +$3K ﹤0.01% 2240
2016
Q4
Sell
-1,213
Closed -$11K 4365
2016
Q3
$11K Sell
1,213
-274
-18% -$2.49K ﹤0.01% 2013
2016
Q2
$12K Buy
1,487
+274
+23% +$2.21K ﹤0.01% 2671
2016
Q1
$8K Buy
1,213
+1,008
+492% +$6.65K ﹤0.01% 2237
2015
Q4
$2K Sell
205
-1,023
-83% -$9.98K ﹤0.01% 3804
2015
Q3
$13K Buy
+1,228
New +$13K ﹤0.01% 2104
2015
Q2
Sell
-5
Closed 4994
2015
Q1
$0 Buy
+5
New ﹤0.01% 4890